[1]
O. Ekinci and I. Kizilkaya, “Imatinib mesylate in first-line treatment of chronic myeloid leukemia ”, Ann Med Res , vol. 26, no. 9, pp. 1737–1743, May 2021, Accessed: Aug. 25, 2026. [Online]. Available: http://www.annalsmedres.org/index.php/aomr/article/view/1748